COHANCE : USFDA CLOSES PASHAMYLARAM FACILITY INSPECTION WITH VAI

• USFDA issued the Establishment Inspection Report (EIR) for the Pashamylaram, Hyderabad manufacturing facility (FEI No. 1000623515) • Inspection outcome classified as Voluntary Action Indicated (VAI) • With receipt of the EIR, the said inspection stands concluded • Update follows the company's earlier communication dated 5 August 2026 on the inspection • Facility is located at Pashamylaram, Hyderabad

Cohance Lifesciences Ltd

Open attachment

← Back to feed